For research use only
| Cat No. | ABC-TC4340 |
| Product Type | Diseased Human Peripheral Blood Mononuclear Cells |
| Cell Type | Mononuclear Cell |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Peripheral Blood |
| Disease | Non-Alcoholic Steatohepatitis |
| Storage | Liquid Nitrogen |
Leverage Human NASH Peripheral Blood Mononuclear Cells to investigate immune dysfunction, systemic inflammation, and biomarkers in fatty liver disease.
Human NASH Peripheral Blood Mononuclear Cells (PBMCs) are immune cells isolated from the peripheral blood of patients with non-alcoholic steatohepatitis (NASH), a progressive form of non-alcoholic fatty liver disease. PBMCs primarily consist of lymphocytes (T cells, B cells, NK cells) and monocytes. They play a critical role in both systemic and hepatic inflammation, a hallmark of NASH. PBMCs contribute to disease progression through the secretion of pro-inflammatory cytokines (e.g., TNF-α, IL-6), immune cell infiltration into the liver, and activation of fibrogenic signaling pathways. These nash pbmc provide a platform to study immune cells in nash, enabling detailed peripheral blood mononuclear cells nash characterization and comprehensive pbmc analysis nash for disease monitoring and therapeutic research.
| Product Code | Human NASH Peripheral Blood Mononuclear Cells, hNASH-PBMC, PBMCs from NASH Patients |
| Species | Human |
| Cat.No | ABC-TC4340 |
| Product Category | Primary Cells |
| Size/Quantity | 1 vial |
| Cell Type | Mononuclear Cell |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Peripheral Blood |
| Disease | Non-Alcoholic Steatohepatitis |
| Storage | Liquid Nitrogen |
| Product Type | Diseased Human Peripheral Blood Mononuclear Cells |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Human NASH Peripheral Blood Mononuclear Cells can be used to explore disease-specific immune dysregulation mechanisms, including abnormal secretion of pro-inflammatory cytokines (such as TNF-α, IL-1β), T cell dysfunction, and differentiation of monocytes to macrophages, which are key processes that promote liver inflammation and fibrosis. They can be used for in vitro drug screening, identification of new biomarkers, and development of immunomodulatory therapies.
When you publish your research, please cite our product as "AcceGen Biotech Cat.# XXX-0000". In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).